Skip to main content

Find Clinical Trials

Home
Conditions
Mesothelioma, Malignant

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

230 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions: ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Florida Cancer Specialists Lake Mary, Florida, United States

Dartmouth Hitchcock Lebanon, New Hampshire, United States

Brown University Health Cancer Institute Providence, Rhode Island, United States

View Trial Details

Recruiting

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

NCT07443020

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +17 more
Locations: AHN West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

NCT07510815

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

NCT05655078

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: East Sussex Healthcare NHS Trust - Eastbourne Hospital Eastbourne, East Sussex, United Kingdom

East Sussex Healthcare NHS Trust - Conquest Hospital Saint Leonards-on-Sea, East Sussex, United Kingdom

Royal Berkshire Hospital Reading, England, United Kingdom

Southend University Hospital Southend, Essex, United Kingdom

View all 25 locations

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

NCT07126509

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +14 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

NCT03760575

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

The IMmunotherapy Pleural 5-ALA PDT

NCT04400539

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +13 more
Locations: Institut Coeur-Poumon, CHU Lille, France

View Trial Details

Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +75 more
Locations: City of Hope Duarte, California, United States

University of Southern California Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

University of Colorado School of Medicine Aurora, Colorado, United States

View all 17 locations

View Trial Details

Recruiting

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

NCT05538806

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Lungenklinik Gauting Gauting, Bavaria, Germany

University Hospital Regensburg Regensburg, Bavaria, Germany

Asklepios Klinikum Harburg Harburg, Free and Hanseatic City of Hamburg, Germany

Klinikum Bremen-Ost Bremen, Free Hanseatic City of Bremen, Germany

View all 23 locations

View Trial Details